Australia markets closed

Sinovac Biotech Ltd. (SVA)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
6.470.00 (0.00%)
As of 04:00PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
448,269
448,269
1,492,761
19,374,904
510,624
Cost of revenue
181,516
181,516
684,456
1,072,221
67,180
Gross profit
266,753
266,753
808,305
18,302,683
443,444
Operating expenses
Research development
344,515
344,515
442,108
155,040
48,760
Selling general and administrative
466,324
466,324
823,543
591,167
176,534
Total operating expenses
791,054
791,054
1,269,159
748,449
227,637
Operating income or loss
-524,301
-524,301
-460,854
17,554,234
215,807
Interest expense
2,260
2,260
1,264
2,836
1,453
Total other income/expenses net
288,413
288,413
296,538
-90,925
333
Income before tax
-153,034
-153,034
25,238
17,563,041
216,617
Income tax expense
105,321
105,321
-62,893
3,104,130
31,438
Income from continuing operations
-258,355
-258,355
88,131
14,458,911
185,179
Net income
-99,918
-99,918
113,866
8,467,480
110,369
Net income available to common shareholders
-105,900
-105,900
107,884
8,461,498
104,354
Basic EPS
85.20
-1.06
1.08
85.20
1.06
Diluted EPS
74.27
-1.06
1.00
74.27
0.97
Basic average shares
99,312
99,608
99,502
99,312
98,897
Diluted average shares
114,006
99,608
114,173
114,006
113,662